TRIMEBUTINE VIATRIS 200 mg, film-coated tablet 30 tablets, CIP 3400930250136
Active ingredients: Trimebutine maleate
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet30 tablets, CIP 3400930250136orale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- TRIMEBUTINE VIATRIS 200 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- flacon(s) polyéthylène haute densité (PEHD) de 30 comprimé(s)
- Marketing authorisation holder
- VIATRIS SANTE
- Reimbursement according to BDPM
- 15 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 24 Oct 2023
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65960119CIP73025013CIP133400930250136Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| MALÉATE DE TRIMÉBUTINEcomprimé | 200 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.